This clinical trial is focused on treating serious infections that require broad-spectrum antibiotics. The study is examining the use of the antibiotic Meropenem, which is commonly used in hospitals to treat severe infections. The trial aims to find the best way to administer this medication to patients in the intensive care unit (ICU). Specifically, it compares two different dosing schedules: one where Meropenem is given in short infusions six times a day, and another where it is given in longer infusions three times a day.

The purpose of the study is to determine if the shorter, more frequent dosing is as effective as the longer, less frequent dosing. Participants in the study will receive one of these two dosing schedules while they are in the ICU. The study will monitor how well the medication works in maintaining adequate levels in the body, as well as other factors like the length of stay in the ICU and any serious side effects that may occur.

This trial is important for optimizing the treatment of serious infections in critically ill patients. By comparing these two dosing methods, the study hopes to improve the effectiveness of Meropenem and potentially enhance patient outcomes in the ICU setting. The study will run for a period of time, and results will be collected to assess which dosing schedule provides the best results for patients.